Company Presentation • 03 Dec 2025 21:00
Company Presentation • 24 Sep 2024 20:30
Company Presentation • 29 Apr 2024 20:30
Company Presentation • 29 Sep 2023 20:30
No more presentations
Search or
𝛼SK
𝛼SKENTITY
Capricor Therapeutics (CAPR US)
Capricor Therapeutics (CAPR US)
5
Analysis
Health Care • United States
Capricor Therapeutics, Inc. operates as a clinical stage biotechnology company. The Company focuses on the development and commercialization of biological therapies for the treatment of duchenne muscular dystrophy (DMD) and other rare disorders. Capricor Therapeutics serves healthcare sector in the United States and Canada.
morex